As of January 2026, the Januvia drug from Merck & Co. had the highest negotiated price reduction of ** percent in the Medicare expenditure drugs in the United States. Fiasp/NovoLog, a drug from Novo Nordisk, negotiated a price reduction of ** percent in the same period. Moreover, the Eliquis price cut is especially significant: apixaban drove 16.5 billion U.S. dollars in U.S. Medicare and commercial spending in 2023, which was the highest ever for a single drug in Medicare history.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
DrugPatentWatch. (March 11, 2026). Price reduction of major Medicare expenditure drugs in the United States as of January 2026 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 04, 2026, from /statistics/1660219/price-reduction-of-medicare-expenditure-drugs-us/
DrugPatentWatch. "Price reduction of major Medicare expenditure drugs in the United States as of January 2026." Chart. March 11, 2026. ÌÇÐÄÆƽâ°æ. Accessed August 04, 2026. /statistics/1660219/price-reduction-of-medicare-expenditure-drugs-us/
DrugPatentWatch. (2026). Price reduction of major Medicare expenditure drugs in the United States as of January 2026. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 04, 2026. /statistics/1660219/price-reduction-of-medicare-expenditure-drugs-us/
DrugPatentWatch. "Price Reduction of Major Medicare Expenditure Drugs in The United States as of January 2026." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 11 Mar 2026, /statistics/1660219/price-reduction-of-medicare-expenditure-drugs-us/
DrugPatentWatch, Price reduction of major Medicare expenditure drugs in the United States as of January 2026 ÌÇÐÄÆƽâ°æ, /statistics/1660219/price-reduction-of-medicare-expenditure-drugs-us/ (last visited August 04, 2026)
Price reduction of major Medicare expenditure drugs in the United States as of January 2026 [Graph], DrugPatentWatch, March 11, 2026. [Online]. Available: /statistics/1660219/price-reduction-of-medicare-expenditure-drugs-us/
